Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Alzheimer's Disease

  Free Subscription


1 Alzheimer Dis Assoc Disord
1 Alzheimers Dement
1 Brain Res
15 J Alzheimers Dis
2 Nat Rev Neurol
1 Neurobiol Aging
1 Neurobiol Dis
2 Neurology
1 Neuropsychology
1 Neuroreport
1 Neurosci Lett
1 Neuroscience
1 PLoS One
1 Proc Natl Acad Sci U S A
1 Rev Neurol (Paris)

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Alzheimer Dis Assoc Disord

  1. MAKRAKIS D, Holt SK, Bernick C, Grivas P, et al
    Intravesical BCG and Incidence of Alzheimer Disease in Patients With Bladder Cancer: Results From an Administrative Dataset.
    Alzheimer Dis Assoc Disord. 2022 Sep 30. pii: 00002093-990000000-00029.
    PubMed         Abstract available

    Alzheimers Dement

  2. STEPHAN BCM, Gaughan DM, Edland S, Gudnason V, et al
    Mid- and later-life risk factors for predicting neuropathological brain changes associated with Alzheimer's and vascular dementia: The Honolulu Asia Aging Study and the Age, Gene/Environment Susceptibility-Reykjavik Study.
    Alzheimers Dement. 2022 Oct 4. doi: 10.1002/alz.12762.
    PubMed         Abstract available

    Brain Res

  3. COSTA AJ, Oliveira RB, Wachilewski P, Nishino MS, et al
    Membrane estrogen receptor ERalpha activation improves tau clearance via autophagy induction in a tauopathy cell model.
    Brain Res. 2022;1795:148079.
    PubMed         Abstract available

    J Alzheimers Dis

  4. JUAREZ-CEDILLO T, Gonzelez-Figueroa E, Gutierez-Gutierez L, Aguilar-Navarro SG, et al
    Prevalence of Dementia and Main Subtypes in Mexico: The Study on Aging and Dementia in Mexico (SADEM).
    J Alzheimers Dis. 2022;89:931-941.
    PubMed         Abstract available

  5. MATSUZAKI TADA A, Hamezah HS, Pahrudin Arrozi A, Abu Bakar ZH, et al
    Pharmaceutical Potential of Casein-Derived Tripeptide Met-Lys-Pro: Improvement in Cognitive Impairments and Suppression of Inflammation in APP/PS1 Mice.
    J Alzheimers Dis. 2022;89:835-848.
    PubMed         Abstract available

  6. PICCARDUCCI R, Caselli MC, Zappelli E, Ulivi L, et al
    The Role of Amyloid-beta, Tau, and alpha-Synuclein Proteins as Putative Blood Biomarkers in Patients with Cerebral Amyloid Angiopathy.
    J Alzheimers Dis. 2022;89:1039-1049.
    PubMed         Abstract available

  7. WATTS A, Chalise P, Hu J, Hui D, et al
    A Mitochondrial DNA Haplogroup Defines Patterns of Five-Year Cognitive Change.
    J Alzheimers Dis. 2022;89:913-922.
    PubMed         Abstract available

  8. DIAZ A, Martin-Jimenez C, Woo Y, Merino P, et al
    Urokinase-Type Plasminogen Activator Triggers Wingless/Int1-Independent Phosphorylation of the Low-Density Lipoprotein Receptor-Related Protein-6 in Cerebral Cortical Neurons.
    J Alzheimers Dis. 2022;89:877-891.
    PubMed         Abstract available

  9. VASSILAKI M, Crowson CS, Davis Iii JM, Duong SQ, et al
    Rheumatoid Arthritis, Cognitive Impairment, and Neuroimaging Biomarkers: Results from the Mayo Clinic Study of Aging.
    J Alzheimers Dis. 2022;89:943-954.
    PubMed         Abstract available

  10. KANG DW, Wang SM, Um YH, Kim NY, et al
    Associations Between Sub-Threshold Amyloid-beta Deposition, Cortical Volume, and Cognitive Function Modulated by APOE varepsilon4 Carrier Status in Cognitively Normal Older Adults.
    J Alzheimers Dis. 2022;89:1003-1016.
    PubMed         Abstract available

  11. ZHANG S, Wei D, Lv S, Wang L, et al
    Scutellarin Modulates the Microbiota-Gut-Brain Axis and Improves Cognitive Impairment in APP/PS1 Mice.
    J Alzheimers Dis. 2022;89:955-975.
    PubMed         Abstract available

  12. DARTORA CM, de Moura LV, Koole M, Marques da Silva AM, et al
    Discriminating Aging Cognitive Decline Spectrum Using PET and Magnetic Resonance Image Features.
    J Alzheimers Dis. 2022;89:977-991.
    PubMed         Abstract available

  13. LIU S, Liu C, Hu W, Ji Y, et al
    Frequency, Severity, and Duration of Autonomic Symptoms in Patients of Prodromal Dementia with Lewy Bodies.
    J Alzheimers Dis. 2022;89:923-929.
    PubMed         Abstract available

  14. SHEN WB, Elahi M, Wang B, Zhan M, et al
    Oxidative Stress Kinase Activation and Impaired Insulin Receptor Signaling Precede Overt Alzheimer's Disease Neuropathology.
    J Alzheimers Dis. 2022 Sep 26. pii: JAD215687. doi: 10.3233/JAD-215687.
    PubMed         Abstract available

  15. WU X, Peng C, Nelson PT, Cheng Q, et al
    Machine Learning Approach Predicts Probability of Time to Stage-Specific Conversion of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 27. pii: JAD220590. doi: 10.3233/JAD-220590.
    PubMed         Abstract available

  16. VALVERDE A, Mitrofanis J
    Photobiomodulation for Hypertension and Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 30. pii: JAD220632. doi: 10.3233/JAD-220632.
    PubMed         Abstract available

  17. LIN J, Yang S, Wang C, Yu E, et al
    Prediction of Alzheimer's Disease Using Patterns of Methylation Levels in Key Immunologic-Related Genes.
    J Alzheimers Dis. 2022 Sep 30. pii: JAD220701. doi: 10.3233/JAD-220701.
    PubMed         Abstract available

  18. GUO Q, Cai Q, Huang F, Wei Z, et al
    The Therapeutic Effects of Seven Lycophyte Compounds on Cell Models of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 29. pii: JAD220704. doi: 10.3233/JAD-220704.
    PubMed         Abstract available

    Nat Rev Neurol

  19. WOOD H
    SNAP25 - an early biomarker in AD and CJD.
    Nat Rev Neurol. 2022;18:575.

  20. MIGLIORE L, Coppede F
    Gene-environment interactions in Alzheimer disease: the emerging role of epigenetics.
    Nat Rev Neurol. 2022 Sep 30. pii: 10.1038/s41582-022-00714.
    PubMed         Abstract available

    Neurobiol Aging

  21. SANLI BA, Whittaker KJ, Motsi GK, Shen E, et al
    Unbiased metabolome screen links serum urate to risk of Alzheimer's disease.
    Neurobiol Aging. 2022;120:167-176.
    PubMed         Abstract available

    Neurobiol Dis

  22. KATSUMATA Y, Shade LM, Hohman TJ, Schneider JA, et al
    Multiple gene variants linked to Alzheimer's-type clinical dementia via GWAS are also associated with non-Alzheimer's neuropathologic entities.
    Neurobiol Dis. 2022 Sep 30:105880. doi: 10.1016/j.nbd.2022.105880.
    PubMed         Abstract available


  23. GALE SA, Heidebrink J, Grill J, Graff-Radford J, et al
    Preclinical Alzheimer Disease and the Electronic Health Record: Balancing Confidentiality and Care.
    Neurology. 2022 Sep 30. pii: WNL.0000000000201347.
    PubMed         Abstract available

  24. Neuropathologic Features of Antemortem Atrophy-Based Subtypes of Alzheimer Disease.
    Neurology. 2022 Sep 30. pii: WNL.0000000000201298.


  25. FREI M, Berres M, Kivisaari SL, Henzen NA, et al
    Can you find it? Novel oddity detection task for the early detection of Alzheimer's disease.
    Neuropsychology. 2022 Oct 6. pii: 2023-07006-001. doi: 10.1037/neu0000859.
    PubMed         Abstract available


  26. WU M, Gao Y, Chen B
    Mechanism of acteoside-activated let-7g-5P attenuating Abeta-induced increased permeability and apoptosis of brain microvascular endothelial cells based on experimental and network pharmacology.
    Neuroreport. 2022;33:714-722.
    PubMed         Abstract available

    Neurosci Lett

  27. WANG Y, Lv S, Zhou X, Niu X, et al
    Identification of hsa-miR-365b-5p's role in Alzheimer's disease: A combined analysis of miRNA and mRNA microarrays.
    Neurosci Lett. 2022;790:136892.
    PubMed         Abstract available


  28. LIN L, Ni L, Wang X, Sheng C, et al
    Longitudinal cognitive change and duration of Alzheimer's disease stages in relation to cognitive reserve.
    Neuroscience. 2022 Sep 28. pii: S0306-4522(22)00487.
    PubMed         Abstract available

    PLoS One

  29. HOHBERGER B, Pruss H, Mardin C, Lammer R, et al
    Glaucoma and Alzheimer: Neurodegenerative disorders show an adrenergic dysbalance.
    PLoS One. 2022;17:e0272811.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  30. HUANG Y, Lemke G
    Early death in a mouse model of Alzheimer's disease exacerbated by microglial loss of TAM receptor signaling.
    Proc Natl Acad Sci U S A. 2022;119:e2204306119.
    PubMed         Abstract available

    Rev Neurol (Paris)

  31. VILLAIN N, Planche V, Levy R
    High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 1: Meta-analysis and review of efficacy and safety data, and medico-economical aspects.
    Rev Neurol (Paris). 2022 Sep 29. pii: S0035-3787(22)00738.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.